CLINICAL_TRIALS
trial_result
· 2017-10-03
Clinical Trial Update: Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo [Phase 3]
Summary
Phase 3 trial update for a sodium pertechnetate injection generator comparing neutron-activation 99Mo to fission 99Mo as a source for 99mTc; the study was termi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Manitoba | Conditions: Cancer of Bone | Phase 3 | Status: TERMINATED | Results posted: 2017-10-03